Nome Azione | Simbolo | Borsa Mercato | Tipo |
---|---|---|---|
Hyloris Pharmaceuticals SA | HYL | Euronext | Azione Ordinaria |
Apertura | Min | Max | Prezzo di chiusura | Chiusura |
---|---|---|---|---|
12,10 |
Ultime notizie
Data | Ora | Fonte | Titolo |
---|---|---|---|
02/5/2023 | 07:00 | GLOBE | Hyloris announces potential registration date for Maxigesic®.. |
28/4/2023 | 07:00 | GLOBE | Hyloris publie son rapport annuel 2022 et ses objectifs ESG |
18/4/2023 | 07:00 | GLOBE | Hyloris annonce la soumission des données relatives au.. |
15/3/2023 | 19:03 | GLOBE | Hyloris reports full year results for 2022 & provides.. |
24/1/2023 | 07:00 | GLOBE | Hyloris Announces Commercial Partnership for Maxigesic® IV.. |
20/1/2023 | 07:00 | GLOBE | Hyloris Pharmaceuticals expands its Pipeline with a Product.. |
22/11/2022 | 18:00 | GLOBE | Hyloris Pharmaceuticals Elargit son Portefeuille de Produits.. |
12/10/2022 | 16:00 | GLOBE | Hyloris Pharmaceuticals Annonce son Déménagement sur le Site.. |
01/9/2022 | 07:00 | GLOBE | Hyloris Pharmaceuticals Reports 2022 Half-Year Results and.. |
20/7/2022 | 07:00 | GLOBE | Hyloris présente des données positives pour la phase 1 de.. |
01/7/2022 | 20:00 | GLOBE | Hyloris Provides Additional Information on U.S. FDA Review.. |
01/7/2022 | 09:55 | GLOBE | US FDA seeks more information on Maxigesic IV® application |